Clinical trials sponsored by Zenas BioPharma (USA), LLC

Phase breakdown

Conditions studied

Recruiting trials led by Zenas BioPharma (USA), LLC

• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
  NCT07067463 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 63 locations
• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
  NCT07299019 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 44 locations
• A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis
  NCT05638854 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is Zenas BioPharma (USA), LLC recruiting for?

Zenas BioPharma (USA), LLC is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.